» Articles » PMID: 35029796

Sigma-1 Receptor Alleviates Airway Inflammation and Airway Remodeling Through AMPK/CXCR4 Signal Pathway

Overview
Journal Inflammation
Date 2022 Jan 14
PMID 35029796
Authors
Affiliations
Soon will be listed here.
Abstract

Sigma non-opioid intracellular receptor 1 (Sigma-1R) has been proven to play a major role in inflammation and structural remodeling. However, its role in airway inflammation and airway remodeling remains unclear. The purpose of this study aimed to explore the role and mechanism of Sigma-1R in airway remodeling and epithelial-mesenchymal transition (EMT) process in vivo and in vitro. We observed the decrease of Sigma-1R in lung tissue of asthma model. In the mouse model of allergic airway inflammation (AAI), Sigma-1R agonist RPE-084 significantly relieved airway inflammation and airway remodeling, while Sigma-1R antagonist BD1047 (B8562) had opposite effects. Further research showed that RPE-084 treatment increased the expression of pAMPK and inhibited the expression of CXCR4. Furthermore, RPE-084 treatment suppressed the levels of IL-4, IL-5, and IL-13 in BALF. We found that RPE-084 or Sigma-1R overexpression vector treatment regulated cell cycle and inhibited cell proliferation, migration, and EMT process in TGF-β1-induced 16HBE cells. Finally, we confirmed that AMP-activated protein kinase (AMPK) inhibitor compound C or CXCR4 agonist ATI-2341 both reversed the effects of Sigma-1R on TGF-β1-induced 16 HBE cells. In a word, our research shows that Sigma-1R is helpful to improve airway remodeling of asthma, and emphasizes a new candidate molecular for asthma treatment.

Citing Articles

Suzi Daotan Decoction alleviates asthmatic airway remodeling through the AMPK/SIRT1/PGC-1α signaling pathway and PI3K/AKT signaling pathway.

Liu K, Liu R, Zhang C, Huang D, Wei B, Song Y Sci Rep. 2025; 15(1):6690.

PMID: 39994309 PMC: 11850920. DOI: 10.1038/s41598-025-90870-y.


LncRNA TCL6 regulates miR-876-5p/MYL2 axis to suppress breast cancer progression.

Liu Y, Li H, Chai D, Lian B, Bai Z, Gao Y Transl Oncol. 2025; 53:102210.

PMID: 39874729 PMC: 11810844. DOI: 10.1016/j.tranon.2024.102210.


Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism-related mechanisms.

Zhan T, Zou Y, Han Z, Tian X, Chen M, Liu J Clin Transl Med. 2024; 14(8):e1799.

PMID: 39118300 PMC: 11310283. DOI: 10.1002/ctm2.1799.


Novel hypoxia-induced HIF-1αactivation in asthma pathogenesis.

Wan M, Yu Q, Xu F, You L, Liang X, Kang Ren K Respir Res. 2024; 25(1):287.

PMID: 39061007 PMC: 11282634. DOI: 10.1186/s12931-024-02869-0.


Medical events in SARS-Cov-2 infected psychiatric inpatients with and without pre-existing co-morbid medical conditions.

Mannekote Thippaiah S, Levitt G, Bains S, Pandurangi A, Ramos G, Bhattarai B Heliyon. 2023; 9(9):e19372.

PMID: 37809864 PMC: 10558328. DOI: 10.1016/j.heliyon.2023.e19372.


References
1.
Yang I, Schwartz D . Epigenetic mechanisms and the development of asthma. J Allergy Clin Immunol. 2012; 130(6):1243-55. PMC: 3518374. DOI: 10.1016/j.jaci.2012.07.052. View

2.
Liu F, Shang Y . Sirtuin 6 attenuates epithelial-mesenchymal transition by suppressing the TGF-β1/Smad3 pathway and c-Jun in asthma models. Int Immunopharmacol. 2020; 82:106333. DOI: 10.1016/j.intimp.2020.106333. View

3.
Foster P, Maltby S, Rosenberg H, Tay H, Hogan S, Collison A . Modeling T 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma. Immunol Rev. 2017; 278(1):20-40. PMC: 5492958. DOI: 10.1111/imr.12549. View

4.
Hall A, Herrera Y, Ajmo Jr C, Cuevas J, Pennypacker K . Sigma receptors suppress multiple aspects of microglial activation. Glia. 2008; 57(7):744-54. PMC: 2692292. DOI: 10.1002/glia.20802. View

5.
Moritz C, Berardi F, Abate C, Peri F . Live imaging reveals a new role for the sigma-1 (σ1) receptor in allowing microglia to leave brain injuries. Neurosci Lett. 2015; 591:13-18. DOI: 10.1016/j.neulet.2015.02.004. View